GoHealth
GOCO
GOCO was delisted on the 15th of June, 2026.
46 hedge funds and large institutions have $51.2M invested in GoHealth in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 9 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 5
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.6% less ownership
Funds ownership: 54.89% → 54.29% (-0.6%)
4% less capital invested
Capital invested by funds: $53.1M → $51.2M (-$1.86M)
10% less funds holding
Funds holding: 51 → 46 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$292K |
| 2 |
Goldman Sachs
New York
|
+$130K |
| 3 |
BlackRock
New York
|
+$99.9K |
| 4 |
Morgan Stanley
New York
|
+$78.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$182K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$143K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$130K |
| 4 |
ABC
Associated Banc-Corp
Green Bay,
Wisconsin
|
-$129K |
| 5 |
Bank of New York Mellon
New York
|
-$126K |
GOCO Hedge Fund Activity: Q3 2024 in Review
46 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in GoHealth (GOCO) for Q3 2024, worth a combined $51.2M — down 3.5% from $53.1M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of GOCO and 4 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 20 added.
The largest buyer was Ameriprise, opening a new position worth an estimated $292K. The largest seller was UBS Group, cutting an estimated $182K.
- 46 institutional investors held GoHealth (GOCO) as of Q3 2024, down from 51 in Q2 2024.
- Funds reported $51.2M of GoHealth stock for Q3 2024, down 3.5% quarter-over-quarter.
- 4 funds opened new GoHealth positions in Q3 2024 and 9 closed out, a net change of -5 holders.
- The largest GoHealth buyer in Q3 2024 was Ameriprise, an estimated $292K added.
- The largest GoHealth seller in Q3 2024 was UBS Group, an estimated $182K sold.
Based on aggregated 13F filings for Q3 2024.